The Medicare GLP-1 Bridge: How to Check If You're Eligible and Apply
On July 1, 2026, CMS launched the Medicare GLP-1 Bridge — a demonstration program that lets eligible Part D beneficiaries access GLP-1 medication for weight management at a $50/month copay. If you're on Medicare and have been priced out of treatment, this is the first real crack in that wall. Here's how to check if you qualify and what to actually do next.
What the Bridge program covers
The program covers brand-name, FDA-approved GLP-1 medications prescribed for weight management through participating Part D plans. It does not extend to compounded versions — compounded semaglutide or tirzepatide from telehealth providers isn't part of this program, since Medicare coverage requires an FDA-approved product with an assigned NDC.
Who's eligible
- Enrolled in a participating Medicare Part D plan
- Meets the clinical criteria for weight management treatment (generally BMI 30+, or BMI 27+ with a weight-related condition)
- Prescribed by a physician who determines the medication is clinically appropriate
Not every Part D plan is participating at launch, and not every beneficiary who meets the BMI threshold will automatically qualify — plan-level rules vary. The most reliable way to check your specific status is directly through CMS's Medicare.gov portal or by calling your plan administrator.
How to actually apply
- Confirm your plan is participating. Call the member services number on your Part D card, or check Medicare.gov's plan finder tool.
- Get a clinical evaluation. Your primary care physician can initiate this, or you can use a telehealth provider that works with brand-name, FDA-approved formulations and Medicare billing.
- Confirm the $50 copay applies to your specific plan and medication. The $50 figure is the demonstration program's target copay, but exact out-of-pocket costs can vary by plan tier.
If you're not eligible, or your plan isn't participating yet
Brand-name options through a telehealth provider like Sesame Care prescribe FDA-approved medication without requiring Medicare enrollment specifically — useful if your plan hasn't opted in yet or you don't meet this program's criteria but still want an FDA-approved (non-compounded) pathway.
Sesame Care From $44
A transparent healthcare marketplace that prescribes FDA-approved brand-name medications only — no compounded formulations. Useful if you want an approved-drug pathway while you sort out Medicare Bridge eligibility.
The bottom line
The Medicare GLP-1 Bridge is new, plan participation is still rolling out, and the fastest way to know your real status is a direct call to your Part D plan — not a guess based on general eligibility rules. If you're not covered yet, an FDA-approved brand-name pathway through telehealth remains available in the meantime.